[Pe-045] English Poster Session 045

[Pe-045-1] HELIOS-A:Study of Vutrisiran in Patients with Hereditary transthyretin-mediated (hATTR) Amyloidosis

^○Yoshiki Sekijima¹, Adams D², Tournev IL^3,4, Taylor MS⁵, Coelho T⁶, Plante-Bordeneuve V⁷, Berk JL⁸, Gonzalez-Duarte A⁹, Gillmore JD¹⁰, Low SC¹¹, Obici L¹², Chen C¹³, Badri P¹³, Arum S¹³, Vest J¹³, Polydefkis M¹⁴ (1.Department of Medicine (Neurology & Rheumatology), Shinshu University School of Medicine, Japan, 2.University College London, Royal Free Hospital, 3.University of Malaya, 4.IRCCS Fondazione Policlinico San Matteo, Pavia, Italy, 5.Alnylam Pharmaceuticals, 6.Johns Hopkins University School of Medicine, 7.APHP, CHU Bicetre, INSERM U1195, Universite Paris-Saclay, 8.University Hospital Aleksandrovska,Medical University - Sofia, 9.New Bulgarian University, 10.Westmead Hospital and Westmead Clinical School, University of Sydney, 11.Hospital de Santo Antonio, Centro Hospitalar do Porto, 12.Neurology - Amyloid network, CHU Henri Mondor - Assistance Publique Hopitaux de Paris, 13.Boston Medical Center, 14.Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran)